Amylyx Pharmaceuticals, Inc. (AMLX)

NMS – Real Time Price. Currency in USD

23.59

-0.04 (-0.17%)

Market open: Aug 12, 2026, 3:04 PM EDT

24.00

+0.37 (1.57%)

Previous after-hours: Aug 11, 2026, 7:50 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

87M

381M

22M

Cost of goods sold

-525K

-126M

-27M

-3M

Gross Profit

-525K

-38M

354M

19M

Operating expenses (excl. COGS)

-153M

-218M

-315M

-220M

Operating Income

-153M

-256M

39M

-201M

Non-operating income, total

-46M

15M

Pretax income

-145M

-302M

54M

-198M

Equity in earnings

Taxes

-46K

393K

-5M

-774K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-145M

-302M

49M

-198M

Discontinued operations

Net income

-145M

-302M

49M

-198M

Dilution adjustment

Preferred dividends

Amylyx Pharmaceuticals, Inc. (AMLX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Amylyx Pharmaceuticals, Inc. (AMLX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Amylyx Pharmaceuticals, Inc. (AMLX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Amylyx Pharmaceuticals, Inc. (AMLX)

Income Statement (Annual)

Income Statement (Annual)